CH
CORT icon

Cromwell Holdings’s Corcept Therapeutics CORT Stock Holding History

Cromwell Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74K Buy
20
+9
+82% +$543 ﹤0.01% 874
2026
Q1 		$443 Buy
+11
New +$411 ﹤0.01% 989

Other funds holding CORT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Cromwell Holdings's CORT Position: Q2 2026 in Review

Cromwell Holdings increased its Corcept Therapeutics (CORT) stake by 82% in Q2 2026, buying an estimated $543 and bringing the position to 20 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #874.

Cromwell Holdings first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Cromwell Holdings held 20 shares of Corcept Therapeutics worth $1.74K as of Q2 2026.
  • Cromwell Holdings bought 9 Corcept Therapeutics shares in Q2 2026, an estimated $543.
  • Corcept Therapeutics made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #874 holding.
  • Cromwell Holdings first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.